Table 4.
Comparison of clinical and laboratory findings in 91 COVID-19 patients in regard to the calcium level
| Variable | Hypocalcemic patients † (n=54) |
Eucalcemic patients †† (n=37) |
P-value |
|---|---|---|---|
| Mean ± SD / Percentage | Mean ± SD / Percentage | ||
| Sex (male) | 60 % | 40 % | 0.52 |
| Age (year) | 55.67 ± 15.9 | 55.11 ± 18.4 | 0.88 |
| Hospitalization (day) | 7.96 ± 3.1 | 6.66 ± 2.8 | 0.17 |
| ICU admission | 33.3% | 9.1% | 0.008* |
| Death | 22.06% | 6.1% | 0.04* |
| Severity | 81.6% | 18.4% | <0.001* |
| Dyspnea | 61.3% | 38.7% | 0.37 |
| O2 saturation | 84.26 ± 12.35 | 89.07 ± 7.57 | 0.05* |
| WBC (×109/μL) | 7.94 ± 5.24 | 6.43 ± 3.11 | 0.9 |
| Lymphocyte (×109/μL) | 1.09 ± 0.56 | 1.25 ± 0.61 0.5 |
0.2 |
| Hemoglobin (g/dL) male | 14.9 ± 1.5 | 14.7 ±1.75 | 0.65 |
| Hemoglobin (g/dL) female | 12.79 ± 2.1 | 12.68 ± 1.35 | 0.86 |
| Albumin (g/dL) | 3.75 ± 0.54 | 3.7 ± 0.42 0.3 |
0.68 |
| Vitamin D (nmol/L) | 73.89 ± 20.38 | 72.1 ± 19.22 | 0.73 |
| PTH (pg/mL) | 46.79 ± 26.75 | 42.57 ±16.46 | 0.41 |
† Serum calcium level ≤8.6 mg/dL
†† Serum calcium level >8.6 mg/dL and ≤ 10.5
* Statistical significance at P< 0.05